SciDev Zukünftiges Wachstum

Future Kriterienprüfungen 4/6

SciDev wird ein jährliches Gewinn- und Umsatzwachstum von 36.9% bzw. 10% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 36.9% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 13.4% betragen.

Wichtige Informationen

36.9%

Wachstumsrate der Gewinne

36.9%

EPS-Wachstumsrate

Chemicals Gewinnwachstum	34.4%
Wachstumsrate der Einnahmen	10.0%
Zukünftige Eigenkapitalrendite	13.4%
Analystenabdeckung	Low
Zuletzt aktualisiert	29 Oct 2024

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

The Return Trends At SciDev (ASX:SDV) Look Promising

Nov 13

Improved Revenues Required Before SciDev Limited (ASX:SDV) Stock's 27% Jump Looks Justified

Sep 30

SciDev Limited's (ASX:SDV) Share Price Is Matching Sentiment Around Its Revenues

Dec 22

Downgrade: What You Need To Know About The Latest SciDev Limited (ASX:SDV) Forecasts

Nov 16

There's Been No Shortage Of Growth Recently For SciDev's (ASX:SDV) Returns On Capital

Oct 25

When Should You Buy SciDev Limited (ASX:SDV)?

May 18

SciDev Limited (ASX:SDV) Stocks Pounded By 30% But Not Lagging Market On Growth Or Pricing

Mar 06

There's Been No Shortage Of Growth Recently For SciDev's (ASX:SDV) Returns On Capital

Feb 28

Analysts Just Published A Bright New Outlook For SciDev Limited's (ASX:SDV)

Oct 28

Why SciDev Limited (ASX:SDV) Could Be Worth Watching

Jun 09

Investors Will Want SciDev's (ASX:SDV) Growth In ROCE To Persist

Feb 02

SciDev's (ASX:SDV) Promising Earnings May Rest On Soft Foundations

Sep 07

Have Insiders Been Buying SciDev Limited (ASX:SDV) Shares?

Feb 01

Gewinn- und Umsatzwachstumsprognosen

ASX:SDV - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (AUD Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
6/30/2027	147	9	9	14	1
6/30/2026	135	8	8	12	1
6/30/2025	121	6	3	9	1
6/30/2024	109	2	4	6	N/A
3/31/2024	100	1	2	5	N/A
12/31/2023	91	0	0	3	N/A
9/30/2023	90	0	0	4	N/A
6/30/2023	90	0	1	5	N/A
3/31/2023	85	0	0	4	N/A
12/31/2022	81	1	-1	2	N/A
9/30/2022	68	0	-2	0	N/A
6/30/2022	56	-1	-4	-1	N/A
3/31/2022	52	0	-2	0	N/A
12/31/2021	48	1	0	2	N/A
9/30/2021	45	2	-1	0	N/A
6/30/2021	43	3	-2	-1	N/A
3/31/2021	36	2	-2	-2	N/A
12/31/2020	30	0	-3	-2	N/A
9/30/2020	24	-1	-2	-1	N/A
6/30/2020	18	-1	-1	0	N/A
3/31/2020	13	-1	-2	-2	N/A
12/31/2019	8	-2	-4	-3	N/A
9/30/2019	5	-2	-3	-2	N/A
6/30/2019	3	-2	-2	-2	N/A
3/31/2019	3	-1	-2	-1	N/A
12/31/2018	2	1	-1	-1	N/A
9/30/2018	2	1	-1	-1	N/A
6/30/2018	2	1	-1	-1	N/A
3/31/2018	2	0	N/A	-1	N/A
12/31/2017	2	-1	N/A	-1	N/A
9/30/2017	2	-1	N/A	0	N/A
6/30/2017	2	-1	N/A	0	N/A
3/31/2017	2	-1	N/A	0	N/A
12/31/2016	2	-1	N/A	0	N/A
9/30/2016	1	-1	N/A	0	N/A
6/30/2016	1	0	N/A	-1	N/A
3/31/2016	1	-1	N/A	-1	N/A
12/31/2015	2	-1	N/A	-1	N/A
9/30/2015	2	-1	N/A	-1	N/A
6/30/2015	2	-1	N/A	-1	N/A
3/31/2015	2	-1	N/A	-1	N/A
12/31/2014	2	-1	N/A	-1	N/A
9/30/2014	1	-1	N/A	-1	N/A
6/30/2014	1	-1	N/A	-1	N/A
3/31/2014	1	-2	N/A	-1	N/A
12/31/2013	1	-2	N/A	0	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: SDVDas prognostizierte Gewinnwachstum (36.9% pro Jahr) liegt über der Sparquote (2.6%).

Ertrag vs. Markt: SDVDie Erträge des Unternehmens (36.9% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Australian (12.5% pro Jahr).

Hohe Wachstumserträge: SDVEs wird erwartet, dass die Erträge des Unternehmens in den nächsten 3 Jahren erheblich steigen werden.

Einnahmen vs. Markt: SDVDie Einnahmen des Unternehmens (10% pro Jahr) werden voraussichtlich schneller wachsen als der Markt Australian (5.8% pro Jahr).

Hohe Wachstumseinnahmen: SDVDie Einnahmen des Unternehmens (10% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: SDVDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich niedrig sein (13.4%).

SciDev Zukünftiges Wachstum

Future Kriterienprüfungen 4/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Price target increased by 29% to AU$0.54

Price target decreased by 7.4% to AU$0.50

Consensus EPS estimates fall by 29%

Price target increased to AU$0.52

Price target decreased to AU$0.75

Price target decreased to AU$1.01

Recent updates

The Return Trends At SciDev (ASX:SDV) Look Promising

Improved Revenues Required Before SciDev Limited (ASX:SDV) Stock's 27% Jump Looks Justified

SciDev Limited, Annual General Meeting, Nov 21, 2024

Full year 2024 earnings: EPS misses analyst expectations

The Return Trends At SciDev (ASX:SDV) Look Promising

SciDev Limited (ASX:SDV) Surges 73% Yet Its Low P/S Is No Reason For Excitement

Price target increased by 29% to AU$0.54

First half 2024 earnings released: EPS: AU$0 (vs AU$0 in 1H 2023)

SciDev (ASX:SDV) Is Looking To Continue Growing Its Returns On Capital

SciDev Limited's (ASX:SDV) Share Price Is Matching Sentiment Around Its Revenues

Downgrade: What You Need To Know About The Latest SciDev Limited (ASX:SDV) Forecasts

There's Been No Shortage Of Growth Recently For SciDev's (ASX:SDV) Returns On Capital

SciDev Limited, Annual General Meeting, Nov 21, 2023

Full year 2023 earnings: EPS and revenues miss analyst expectations

Price target decreased by 7.4% to AU$0.50

When Should You Buy SciDev Limited (ASX:SDV)?

Consensus EPS estimates fall by 29%

SciDev Limited (ASX:SDV) Stocks Pounded By 30% But Not Lagging Market On Growth Or Pricing

There's Been No Shortage Of Growth Recently For SciDev's (ASX:SDV) Returns On Capital

First half 2023 earnings released: EPS: AU$0 (vs AU$0.014 loss in 1H 2022)

Independent & Non-Executive Director recently bought AU$80k worth of stock

Price target increased to AU$0.52

SciDev Ltd Appoints Seán Halpin as Chief Executive Officer

Analysts Just Published A Bright New Outlook For SciDev Limited's (ASX:SDV)

SciDev Limited, Annual General Meeting, Nov 15, 2022

Full year 2022 earnings released: AU$0.003 loss per share (vs AU$0.023 profit in FY 2021)

Why SciDev Limited (ASX:SDV) Could Be Worth Watching

Price target decreased to AU$0.75

First half 2022 earnings: EPS exceeds analyst expectations

Investors Will Want SciDev's (ASX:SDV) Growth In ROCE To Persist

SciDev Limited Ordinary Shares to Be Deleted from Other OTC

Interim Chief Financial Officer Geoff Stephenson has left the company

Price target decreased to AU$1.01

SciDev's (ASX:SDV) Promising Earnings May Rest On Soft Foundations

Full year 2021 earnings released: EPS AU$0.023 (vs AU$0.007 loss in FY 2020)

High number of new and inexperienced directors

Non-Executive Chairman Trevor Jones has left the company

SciDev Limited (ASX:SDV) completed the acquisition of Business of Haldon Industries.

SciDev Limited Maxiflox Contract with Eramet Subsidiary SLN

New 90-day low: AU$0.65

First half 2021 earnings released: EPS AU$0.003 (vs AU$0.002 loss in 1H 2020)

SciDev Limited Announces Executive Changes

Revenue beats expectations

SciDev Limited Names Dan O'Toole BEng to the Board as an Independent, Non-Executive Director

Have Insiders Been Buying SciDev Limited (ASX:SDV) Shares?

New 90-day low: AU$0.70

SciDev Limited Provides an Update on the Increased Activity Levels Within the US Oil and Gas Sector

MD, CEO & Executive Director exercised options and sold AU$517k worth of stock

New 90-day high: AU$0.90

Non-Executive Chairman recently bought AU$62k worth of stock

Non-Executive Chairman recently bought AU$62k worth of stock

Earnings released

New 90-day high - AU$0.88

SciDev Limited has completed a Follow-on Equity Offering in the amount of AUD 2 million.

Gewinn- und Umsatzwachstumsprognosen

Analystenprognosen zum zukünftigen Wachstum

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Wachstumsunternehmen entdecken